GeoVax Labs, Inc. 8-K

What Happened
GeoVax Labs, Inc. (GOVX) filed an 8-K on July 10, 2026 reporting that on July 7, 2026 the Nasdaq Listing Qualifications Staff notified the company it is not in compliance with the $2,500,000 minimum stockholders’ equity requirement under Nasdaq Listing Rule 5550(b)(1). Nasdaq also indicated GeoVax did not meet the alternative standards based on market value of listed securities or net income from continuing operations as of the notice date. The notice itself does not immediately affect the company’s Nasdaq listing and the common stock continues to trade under the symbol “GOVX.”

Key Details

• Notice date: July 7, 2026; 8-K filed July 10, 2026.
• Listing rule cited: Nasdaq Listing Rule 5550(b)(1) — $2,500,000 minimum stockholders’ equity.
• Compliance timeline: GeoVax has 45 calendar days (until August 21, 2026) to submit a plan to regain compliance; if Nasdaq accepts the plan, it may grant up to a 180-day extension to demonstrate compliance.
• Next steps: The company intends to submit a plan and is evaluating options; if Nasdaq rejects the plan or compliance is not achieved, Nasdaq would issue a delisting determination (the company may request a hearing to stay delisting).

Why It Matters
This notice signals a risk that GeoVax could be delisted from Nasdaq if it cannot restore compliance, which can reduce liquidity, limit investor access, and negatively affect share price. However, there is no immediate trading impact — the stock remains listed while the company seeks to remedy the deficiency. Investors should monitor forthcoming filings (the compliance plan, any Nasdaq responses, and possible hearing requests) for updates on the company’s ability to regain compliance.